Market Exclusive

Analyst Activity – Piper Jaffray Companies Reiterates Hold on Arrowhead Pharmaceuticals (NASDAQ:ARWR)

Analyst Ratings For Arrowhead Pharmaceuticals (NASDAQ:ARWR)

Today, Piper Jaffray Companies reiterated its Hold rating on Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a price target of $2.00.

There are 5 hold ratings on the stock.

The current consensus rating on Arrowhead Pharmaceuticals (NASDAQ:ARWR) is Hold (Score: 2.00) with a consensus target price of $1.80 per share, a potential 0.56% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Arrowhead Pharmaceuticals (NASDAQ:ARWR) has insider ownership of 4.57% and institutional ownership of 32.75%.

Recent Trading Activity for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Shares of Arrowhead Pharmaceuticals closed the previous trading session at 1.79 down -0.06 -3.24% with 986,852 shares trading hands.

Exit mobile version